Skip to content
Preprint · CC-BY via OpenAlex

[Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease].

Yifeng Li, Guihong Chen, Meijun Chen, Yan Lin, Cheng Luo, Lingxin Guo, Wenbao Hu, Zhengzhao Liu

PubMed · 2025

Abstract

Klotho (KL) protein is a key renoprotective protein that exerts organ-protective effects through regulation of mineral metabolism, anti-inflammatory and antioxidant activity, anti-aging signaling, modulation of autophagy(definition), and inhibition of fibrosis. KL levels decline from the early stage of chronic kidney disease (CKD) and are correlated with disease severity, indicating its strong potential as an early diagnostic biomarker. However, current KL-targeted therapies have not yet achieved clinical translation. Recent studies demonstrate that engineered fibroblast growth factor-23 (FGF-23) binding peptides show up to a 2 300-fold increase in affinity for KL, providing a basis for developing high-sensitivity KL assays. In parallel, persistent activation of endoplasmic reticulum (ER)-associated degradation (ERAD) may represent a major mechanism driving KL ubiquitination and degradation. The emerging deubiquitinase-targeting chimera (DUBTAC) technology protects target proteins from degradation by inhibiting their ubiquitination. The combination of engineered FGF-23 binding peptides and KL-targeted DUBTAC technology may accelerate clinical development of sensitive detection and targeted therapeutic strategies for KL, holding substantial clinical significance for CKD management.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.11817/j.issn.1672-7347.2025.250245
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Li, Y., Chen, G., Chen, M., Lin, Y., Luo, C., Guo, L., Hu, W., &amp; Liu, Z. (2025). [Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease]. <em>PubMed</em>. https://doi.org/10.11817/j.issn.1672-7347.2025.250245
Vancouver
Li Y, Chen G, Chen M, Lin Y, Luo C, Guo L, et al. [Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease]. PubMed. 2025. doi:10.11817/j.issn.1672-7347.2025.250245.
BibTeX
@unpublished{yifeng2025Potent, title = {[Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease].}, author = {Yifeng Li and Guihong Chen and Meijun Chen and Yan Lin and Cheng Luo and Lingxin Guo and Wenbao Hu and Zhengzhao Liu}, journal = {PubMed}, year = {2025}, doi = {10.11817/j.issn.1672-7347.2025.250245}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings